Open Access

New developments in NOACs and TAVI: How do we apply them in clinical practice?

Congress Session

About the speaker

Professor Davide Capodanno

University of Catania, Catania (Italy)
26 presentations

3 more presentations in this session

Welcome and introduction.

Speaker: Doctor S. Saito (Kamakura, JP)


Edoxaban in patients with AF following TAVI: ENVISAGE-TAVI AF trial results.

Speaker: Professor N. van Mieghem (Rotterdam, NL)


Panel discussion.


Access the full session

Anticoagulation in Transcatheter Aortic Valve Implantation in Patients with Atrial Fibrillation: Results from ENVISAGE-TAVI AF trial.

Speakers: Professor D. Capodanno, Doctor S. Saito, Professor N. van Mieghem

About the event


ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Related content

ACVC Premium Access

Proposed treatment after TTM2.

18 March 2022

ACVC Premium Access

TTM2: a game changer?

18 March 2022

ACVC Premium Access

Clinical trial evidence.

18 March 2022

This platform is supported by

logo Novo Nordisk